dc.contributor.advisor	Culver, James
dc.contributor.author	Shareef, Napiera
dc.contributor.department	Honors	en_US
dc.date.accessioned	2016-02-17T16:46:35Z
dc.date.available	2016-02-17T16:46:35Z
dc.date.issued	2016-02-15
dc.description.abstract	Some people are born with immunity to HIV/AIDS due to a genetic mutation, which causes misshapen proteins to form on the surface of their white blood cells. The deformed proteins prevent the HIV/AIDS virus from binding to the cells and ultimately infecting them. Using gene therapy, we can manually insert this mutation into cells and prevent them from getting infected by the HIV/AIDs virus.	en_US
dc.identifier	https://doi.org/10.13016/M2MT6S
dc.identifier.uri	http://hdl.handle.net/1903/17435
dc.language.iso	en_US	en_US
dc.relation.isAvailableAt	Digital Repository at the University of Maryland
dc.relation.isAvailableAt	University of Maryland (College Park, Md)
dc.subject	HIV	en_US
dc.subject	Zinc	en_US
dc.subject	Zinc Finger Nucleases	en_US
dc.subject	DNA	en_US
dc.subject	AIDS	en_US
dc.title	Using Zinc Finger Nucleases and Homologous Recombination to Treat HIV/AIDs	en_US
dc.type	Research Paper	en_US

Using Zinc Finger Nucleases and Homologous Recombination to Treat HIV/AIDs

Files